{"disease":{"id":"neurogenetic-diseases","name":"neurogenetic diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06955624","title":"Use of Omics Methods to Classify Variations of Uncertain Significance and Improve Diagnosis of Neurogenetic Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":95,"lead_sponsor_name":"University Hospital, Rouen","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}